MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 11.02.2026
Johnson & Johnson Kurzfristige Verbindlichkeiten 2011-2026 | JNJ
Kurzfristige Verbindlichkeiten Jährlich Johnson & Johnson
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 54.1 B | 50.3 B | 46.3 B | 45.2 B | 42.5 B | - | 36 B | 31.2 B | 30.5 B | 27.7 B | - | 25.1 B | 25.7 B | 24.3 B | 23.1 B |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 54.1 B | 23.1 B | 35.5 B |
Kurzfristige Verbindlichkeiten anderer Aktien in der Pharmaeinzelhändler
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Apellis Pharmaceuticals
APLS
|
324 M | $ 20.32 | -1.86 % | $ 2.56 B |  USA |
 |
Aptorum Group Limited
APM
|
4.34 M | $ 0.82 | -2.7 % | $ 4.47 M |  China |
 |
Axsome Therapeutics
AXSM
|
379 M | $ 165.39 | -0.6 % | $ 8.23 B | USA |
 |
I-Mab
IMAB
|
576 M | - | - | $ 866 M | China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
1.62 B | - | - | $ 40.3 B | USA |
 |
AbCellera Biologics
ABCL
|
64.3 M | $ 3.65 | -4.58 % | $ 1.09 B |  Canada |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.77 M | - | -1.52 % | $ 24.7 M | USA |
 |
Adverum Biotechnologies
ADVM
|
22.9 M | - | - | $ 86.2 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
556 M | - | - | - |  Russia |
 |
Corvus Pharmaceuticals
CRVS
|
6.87 M | $ 17.24 | -3.63 % | $ 828 M | USA |
 |
ARCA biopharma
ABIO
|
13 M | - | 1052.0 % | $ 415 M | USA |
 |
Acer Therapeutics
ACER
|
19 M | - | 2.71 % | $ 14 M | USA |
 |
Alpine Immune Sciences
ALPN
|
58 M | - | - | $ 2.17 B | USA |
 |
Acorda Therapeutics
ACOR
|
228 M | - | -24.86 % | $ 820 K | USA |
 |
Capricor Therapeutics
CAPR
|
31.3 M | $ 25.62 | -4.62 % | $ 686 M | USA |
 |
Acasti Pharma
ACST
|
1.93 M | - | 4.01 % | $ 150 M | Canada |
 |
AgeX Therapeutics
AGE
|
5.91 M | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
58.7 M | - | - | $ 1.01 B | USA |
 |
Codexis
CDXS
|
23.6 M | $ 0.99 | -2.59 % | $ 72.7 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
25.2 M | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
3.78 M | - | 1.93 % | $ 17.4 M | USA |
 |
Agenus
AGEN
|
256 M | $ 3.18 | -4.94 % | $ 1.14 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
7.54 M | - | - | $ 7.46 M |  Israel |
 |
Akero Therapeutics
AKRO
|
39.8 M | - | - | $ 3.67 B | USA |
 |
Agios Pharmaceuticals
AGIO
|
82.2 M | $ 28.47 | -2.5 % | $ 1.65 B | USA |
 |
Advaxis
ADXS
|
25 M | - | -9.65 % | $ 45.9 M | USA |
 |
Akouos
AKUS
|
16.8 M | - | 0.23 % | $ 488 M | USA |
 |
Завод ДИОД
DIOD
|
105 M | - | - | - | Russia |
 |
Фармсинтез
LIFE
|
1.02 B | - | - | - | Russia |
 |
Albireo Pharma
ALBO
|
45.3 M | - | -0.23 % | $ 916 M | USA |
 |
Alector
ALEC
|
69.5 M | $ 2.13 | -3.39 % | $ 219 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
15.7 M | - | 3.16 % | $ 1.9 M | USA |
 |
Aileron Therapeutics
ALRN
|
5.75 M | - | 10.36 % | $ 9.8 M | USA |
 |
Altimmune
ALT
|
10.5 M | $ 4.15 | -0.24 % | $ 295 M | USA |
 |
Teligent, Inc.
TLGT
|
23.1 M | - | -13.85 % | $ 16.1 M | USA |
 |
AlloVir
ALVR
|
5.24 M | - | 4.14 % | $ 49.1 M | USA |
 |
Viela Bio, Inc.
VIE
|
46 M | - | - | $ 2.91 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
2.38 M | - | -11.43 % | $ 502 K | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
147 M | $ 24.06 | 0.75 % | $ 2.94 B | USA |
 |
Amarin Corporation plc
AMRN
|
194 M | $ 13.95 | 0.14 % | $ 5.79 B |  Irlanda |
 |
AbbVie
ABBV
|
43.3 B | $ 231.93 | -0.98 % | $ 410 B | USA |
 |
Blueprint Medicines Corporation
BPMC
|
261 M | - | - | $ 8.14 B | USA |
 |
Applied Molecular Transport
AMTI
|
15.1 M | - | - | $ 10.1 M | USA |